Literature DB >> 17851862

Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques--a retrospective analysis.

Lucyna Kepka1, Krzysztof Bujko, Agnieszka Zolciak-Siwinska.   

Abstract

PURPOSE: To estimate retrospectively the rate of isolated nodal failures (INF) in NSCLC patients treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT). MATERIALS/
METHODS: One hundred and eighty-five patients with I-IIIB stage treated with 3D-CRT in consecutive clinical trials differing in an extent of the ENI were analyzed. According to the extent of the ENI, two groups were distinguished: extended (n = 124) and limited (n = 61) ENI. INF was defined as regional nodal failure occurring without local progression. Cumulative Incidence of INF (CIINF) was evaluated by univariate and multivariate analysis with regard to prognostic factors.
RESULTS: With a median follow up of 30 months, the two-year actuarial overall survival was 35%. The two-year CIINF rate was 12%. There were 16 (9%) INF, eight (6%) for extended and eight (13%) for limited ENI. In the univariate analysis bulky mediastinal disease (BMD), left side, higher N stage, and partial response to RT had a significant negative impact on the CIINF. BMD was the only independent predictor of the risk of incidence of the INF (p = 0.001).
CONCLUSIONS: INF is more likely to occur in case of more advanced nodal status.

Entities:  

Mesh:

Year:  2008        PMID: 17851862     DOI: 10.1080/02841860701441855

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  6 in total

1.  Stereotactic body radiation therapy (SBRT) for early stage lung cancer delivers clinically significant radiation to the draining lymph nodes.

Authors:  Bhupesh Parashar; Prabhsimranjot Singh; Paul Christos; Shruthi Arora; Prashant Desai; A Gabriella Wernicke; Marylynn Delamerced; Dustin Boothe; Dattatreyudu Nori; Ksc Chao
Journal:  J Radiosurg SBRT       Date:  2013

Review 2.  Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges.

Authors:  Satoshi Ishikura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-15

3.  Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.

Authors:  Aparna H Kesarwala; Christine J Ko; Holly Ning; Eric Xanthopoulos; Karl E Haglund; William P O'Meara; Charles B Simone; Ramesh Rengan
Journal:  Clin Lung Cancer       Date:  2014-12-09       Impact factor: 4.785

4.  Stereotactic body radiation therapy (SBRT) for early stage lung cancer delivers clinically significant radiation to the draining lymph nodes.

Authors:  Bhupesh Parashar; Prabhsimranjot Singh; Paul Christos; Shruthi Arora; Prashant Desai; A Gabriella Wernicke; Marylynn Delamerced; Dustin Boothe; Dattatreyudu Nori; Ksc Chao
Journal:  J Radiosurg SBRT       Date:  2013

5.  The analysis of prognostic factors affecting post-radiation acute reaction after conformal radiotherapy for non-small cell lung cancer.

Authors:  Michał Spych; Leszek Gottwald; Małgorzata Klonowicz; Michał Biegała; Robert Bibik; Jacek Fijuth
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

6.  Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer.

Authors:  Mao-Bin Meng; Huan-Huan Wang; Nicholas G Zaorsky; Xian-Zhi Zhao; Zhi-Qiang Wu; Bo Jiang; Yong-Chun Song; Hong-Qing Zhuang; Feng-Tong Li; Lu-Jun Zhao; Chang-Li Wang; Kai Li; Ping Wang; Zhi-Yong Yuan
Journal:  Oncotarget       Date:  2015-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.